|Articles|November 2, 2001
- Pharmaceutical Technology-11-02-2001
- Volume 25
- Issue 11
Manufacturers Face Challenges and Regulatory Changes
Author(s)Jill Wechsler
Threats of bioterrorism generate new reulatory policies to protect the public against biological warfare.
Advertisement
Articles in this issue
about 24 years ago
blankabout 24 years ago
Truth in Outsourcingabout 24 years ago
One-Step Aqueous Enteric Coating Systems: Scale-Up Evaluationabout 24 years ago
Filter Integrity Testing in Liquid Applications, Revisited Part IIabout 24 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
FDA Deploys Agentic AI Capabilities for Agency Staff
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
5
